| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |